About Invictus Oncology Private Limited
Data last updated:
Invictus Oncology Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 April 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC217394. Its GSTIN is 07AACCI5921K1ZH (Delhi).
The company has an authorised share capital of ₹2.1 Cr and a paid-up capital of ₹2.06 Cr. It is led by directors including Raghunath Anant Mashelkar and Shiladitya Sengupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 465; F.I.E. 1st Floor Pathparganj Industrial Area, Delhi, India – 110092.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.86 Cr, a growth of 20% compared to the previous year. For the same year it recorded a net loss of ₹5.64 Lakh (net margin -2%) and EBITDA of ₹8.01 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years and 63% over five years.
The company is associated with 1 brand: Invictus Oncology. The company has 10 deals on record (6 funding rounds, 3 convertible or debt financings, 1 secondary share transfer), with disclosed funding of ₹38.67 Cr; the latest was in December 2016.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website invictusoncology.com.
Company details
Contact details
Invictus Oncology Private Limited's registered office is in Delhi, Delhi. Its website is invictusoncology.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressPlot No. 465; F.I.E. 1st Floor Pathparganj Industrial Area, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Invictus Oncology Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Invictus Oncology operates one associated brand: Invictus Oncology. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Chemotherapeutics conjugated with antibodies are developed for cancer treatment. | invictusoncology.com |
Business activity
The main business activity of Invictus Oncology is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Invictus Oncology Private Limited, buy the company report.
Financials of Invictus Oncology Private Limited
FY 2025 filings availableInvictus Oncology Private Limited reported revenue of ₹2.86 Cr (up 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 63% over five years, including 20% growth in the latest year. EBITDA fell 69% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹5.64 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | -2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Invictus Oncology Private Limited, buy the company report.
Board of directors of Invictus Oncology Private Limited
Invictus Oncology has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raghunath Anant Mashelkar Also directs: Sakal Media Private Limited, Akamara Biomedicine Private Limited, Vyome Therapeutics Limited and 5 more | Director | 04 Feb 2013 | 13 Years 9 Months | Current |
| Rajeev Mantri Also directs: Akamara Biomedicine Private Limited, Vyome Biosciences Private Limited, Navam Technology Ventures LLP and 5 more | Nominee Director | 11 Apr 2011 | 15 Years 6 Months | Current |
| Shiladitya Sengupta Also directs: Akamara Biomedicine Private Limited, Vyome Therapeutics Limited, Vyome Biosciences Private Limited and 1 more | Director | 11 Apr 2011 | 15 Years 6 Months | Current |
| Jasmin Rambhai Patel | Nominee Director | 04 Feb 2013 | 13 Years 9 Months | Current |
Auditor
Invictus Oncology Private Limited is audited by B R MAHESWARI & CO LLP for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B R MAHESWARI & CO LLP | FY 2020 | 001035N |
Shareholding
The shareholding of Invictus Oncology Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Invictus Oncology Private Limited, buy the company report.
Deals & funding
Invictus Oncology Private Limited has 10 deals on record (6 funding rounds, 3 convertible or debt financings, 1 secondary share transfer), with disclosed funding of ₹38.67 Cr; the latest was in December 2016.
Deals on record (4 of 10)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2014 | Funding round | ₹2.5 Cr | Investors: Navam Capital |
| Feb 2013 | Funding round · Seed | ₹10.5 Cr | Investors: Aarin Capital, Navam Capital, Consilium Ventures |
| Jan 2013 | Funding round | ₹20,000 | Investors: 4 individuals |
| Jan 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Invictus Oncology Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Invictus Oncology Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Invictus Oncology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Invictus Oncology has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCI5921K1ZH | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Invictus Oncology Private Limited, buy the company report.
Recent activity
Invictus Oncology Private Limited has 7 board changes on record since 2011: 4 appointments and 3 cessations. The latest: Jasmin Rambhai Patel ceased to be Additional Director on 10 Jun 2013.
Frequently asked questions
Invictus Oncology is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 April 2011 (15+ years old) and is registered under CIN U24232DL2011PTC217394.
Invictus Oncology has 4 current directors:
- Raghunath Anant Mashelkar - Director
- Rajeev Mantri - Nominee Director
- Shiladitya Sengupta - Director
- Jasmin Rambhai Patel - Nominee Director
The latest financial statements of Invictus Oncology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Invictus Oncology is 07AACCI5921K1ZH, registered in Delhi.
The CIN (Corporate Identification Number) of Invictus Oncology is U24232DL2011PTC217394. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Invictus Oncology was incorporated on 11 April 2011, making it 15+ years old. It is registered with the Registrar of Companies, Delhi.
Invictus Oncology has 10 deals on record (6 funding rounds, 3 convertible or debt financings, 1 secondary share transfer), with disclosed funding of ₹38.67 Cr; the latest was in December 2016.
Jasmin Rambhai Patel ceased to be Additional Director on 10 Jun 2013. Raghunath Anant Mashelkar ceased to be Additional Director on 10 Jun 2013. Rajeev Mantri ceased to be Director on 10 Jun 2013. Invictus Oncology has 7 board changes on record in total.
Invictus Oncology can be reached through the website invictusoncology.com. Its registered office is in Delhi, India.
The registered office of Invictus Oncology is at Plot No. 465; F.I.E. 1st Floor Pathparganj Industrial Area, Delhi, India – 110092.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
